Sleep architecture in COPD patients during salmeterol versus tiotropium bromide treatment Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006
The effect of tiotropium in the treatment of patients with COPD Source: Annual Congress 2010 - COPD: management Year: 2010
The effect of formoterol in elderly COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 122s Year: 2005
Influence of tiotropium bromide on quantity of exacerbations and survival rate of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007
The role of tiotropium bromide in physical training for patients with COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Long-term efficacy of twice-daily aclidinium bromide in COPD patients: A one-year study Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Twice-daily aclidinium bromide in COPD patients: A pooled analysis of lung function in the ACCORD-COPD I and ATTAIN trials Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Improvement in COPD symptoms with aclidinium bromide vs placebo and tiotropium: A phase IIIb study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013
Effects of twice-daily aclidinium bromide in COPD patients: A long-term extension of ACCORD-COPD I Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
The influence of tiotropium bromide on neutrophiles function of bronchial region in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010
Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
The improvement of the macrophages morphological characteristics in bronchial region in stable COPD patients under the influence of tiotropium bromide Source: Annual Congress 2010 - COPD: management Year: 2010
Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002
Comparative study of one-year treatment with salmeterol along, and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructi e pulmonary diseases (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Bronchodilator effects of aclidinium bromide, a novel long-acting anticholinergic, in COPD patients: a phase II study Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe COPD in France Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017